已发表论文

关于粗梁-团块型肝细胞肝癌:我们应该知道什么?

 

Authors Li X, Yao Q, Liu C , Wang J, Zhang H, Li S, Cai P

Received 5 March 2022

Accepted for publication 23 April 2022

Published 5 May 2022 Volume 2022:9 Pages 379—387

DOI https://doi.org/10.2147/JHC.S364742

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Ahmed O Kaseb

摘要:肝细胞肝癌(Hepatocellular carcinomaHCC) 是肝脏最常见的原发恶性肿瘤,最近,HCC 的最新特殊病理亚型:粗梁团块型 HCCMacrotrabecular-massive hepatocellular carcinomaMTM-HCC)(粗梁 >个细胞厚度且所占肿瘤比例 >50%),由于其恶性程度较高,受到临床学者的广泛关注。MTM-HCC 是影响早期复发和总生存率的独立预后指标,这主要由 MTM-HCC 的分子分型、基因突变、癌变途径和免疫组织化学决定。此外,术前影像学检查可为 MTM-HCC 的诊断提供重要线索,Gd-EOB-DTPA 增强 MRI 或 CT 显示肿瘤内坏死或缺血是 MTM-HCC 的独立危险因素。MTM-HCC 的早期诊断和个性化治疗有助于预防早期复发和改善预后。
Keywords: hepatocellular carcinoma, macrotrabecular-massive, molecular subclass, gene mutation, magnetic resonance imaging